chitosan has been researched along with glycylglycine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Huang, Z; Li, D; Liu, X; Lou, Y; Lu, B; Xiong, F; Xu, H; Xu, P; Yin, Y; Zhang, X; Zheng, H | 1 |
| Bahari Javan, N; Dehpour, AR; Dorkoosh, F; Jafary Omid, N; Partoazar, A; Rafiee Tehrani, M | 1 |
2 other study(ies) available for chitosan and glycylglycine
| Article | Year |
|---|---|
A novel melphalan polymeric prodrug: preparation and property study.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Chitosan; Drug Carriers; Glycylglycine; Humans; Melphalan; Multiple Myeloma; Nanoparticles; Polymers; Prodrugs; Solubility | 2014 |
In-vitro and in-vivo cytotoxicity and efficacy evaluation of novel glycyl-glycine and alanyl-alanine conjugates of chitosan and trimethyl chitosan nano-particles as carriers for oral insulin delivery.
Topics: Administration, Oral; Animals; Blood Glucose; Caco-2 Cells; Cell Survival; Chitosan; Dipeptides; Drug Carriers; Drug Liberation; Glycylglycine; Humans; Hypoglycemic Agents; Insulin; Magnetic Resonance Spectroscopy; Male; Nanoparticles; Permeability; Rats, Wistar; Spectrophotometry, Infrared | 2018 |